Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Status: Enrolling
Updated:  12/31/1969
VA North Texas Health Care System
mi
from
Dallas, TX
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Status: Enrolling
Updated: 12/31/1969
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Heart and Vascualr Institute
mi
from
Elk Grove Village, IL
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Heart and Vascualr Institute
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Piedmont Healthcare
mi
from
Atlanta, GA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Piedmont Healthcare
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Advocate Health and Hospitals Corp.
mi
from
Oakbrook Terrace, IL
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Advocate Health and Hospitals Corp.
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Saint Lukes Hospital
mi
from
Kansas City, MO
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated:  12/31/1969
New Mexico Heart Institute
mi
from
Albuquerque, NM
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated: 12/31/1969
New Mexico Heart Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects: A Pilot Trial
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects: A Pilot Trial
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
COcoa Supplement and Multivitamin Outcomes Study
COcoa Supplement and Multivitamin Outcomes Study
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
COcoa Supplement and Multivitamin Outcomes Study
COcoa Supplement and Multivitamin Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
COcoa Supplement and Multivitamin Outcomes Study
COcoa Supplement and Multivitamin Outcomes Study
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
COcoa Supplement and Multivitamin Outcomes Study
COcoa Supplement and Multivitamin Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Gilbert, AZ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Long Beach, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Newport Beach, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Pasadena, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Colorado Springs, CO
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Danbury, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Danbury, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Fairfield, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Fairfield, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Stamford, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Stamford, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Atlantis, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Hialeah, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Avon, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Franklin, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Franklin, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #146
mi
from
Lexington, KY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #146
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Kansas City, MO
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Great Falls, MT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #140
mi
from
Reno, NV
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #140
mi
from
Reno, NV
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New Brunswick, NJ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
White Plains, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
White Plains, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Mooresville, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Mooresville, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Raleigh, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Winston-Salem, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Corvallis, OR
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Corvallis, OR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Dallas, TX
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Sacramento, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials